Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Unleash Immuno Oncolytics

Unleash Immuno Oncolytics
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Debt LATEST DEAL TYPE
$3M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of oncolytic virus immunotherapy products designed to treat cancer. The company's immunotherapy products include UIO-512, which is an oncolytic virus designed targeting both malignant cells and tumor-associated stroma cells, enabling patients to start cancer treatment more quickly, resulting in a better medical outcome.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 4240 Duncan Avenue
  • Suite 200
  • Saint Louis, MO 63110
  • United States

+1 (314) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Unleash Immuno Oncolytics’s full profile, request a free trial.

Unleash Immuno Oncolytics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - General 19-Feb-2018 $3M 000 Completed Startup
2. Seed Round 12-May-2016 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Unleash Immuno Oncolytics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Axia Ventures Venture Capital Minority 000 0000 000000 0
BioGenerator Venture Capital Minority 000 0000 000000 0
Cygnus Capital Accelerator/Incubator Minority 000 0000 000000 0

Unleash Immuno Oncolytics Executive Team (6)

Name Title Board
Seat
Contact
Info
Daniel Katzman Chief Executive Officer & Board Member
Ariel Muslera Chief Financial Officer & Board Member
Marina Scuseria Advisor
Osvaldo Podhajcer Ph.D Lead Scientific Advisor
Ronald Alvarez MD SAB Advisor
You’re viewing 5 of 6 executives. Get the full list »

Unleash Immuno Oncolytics Board Members (4)

Name Representing Role Since Contact
Info
Ariel Muslera Unleash Immuno Oncolytics Chief Financial Officer & Board Member 000 0000
Charles Bolten BioGenerator Board Member 000 0000
Daniel Katzman Unleash Immuno Oncolytics Chief Executive Officer & Board Member 000 0000
Lisandro Bril Self Chairman of the Board 000 0000